311
Participants
Start Date
March 31, 2011
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2016
haloperidol decanoate
haloperidol decanoate injections, 25-200 mg once a month
paliperidone palmitate
Paliperidone palmitate injections, 39 mg - 234 mg once a month
Research Foundation for Mental Hygiene, New York
University of Rochester, Rochester
Philadelphia VA Medical Center-116A, Philadelphia
Clinical Insights, Inc., Glen Burnie
John Umstead Hospital/Duke University, Butner
Carolina Behavioral Care, Durham
Medical College of Georgia, Augusta
University of Miami School of Medicine, Miami
Louis Stokes Cleveland VA Medical Center, Brecksville
John D. Dingell VA Medical Center, Detroit
Sparrow St. Lawrence Hospital, Michigan State University Psychiatry, Lansing
University of Iowa Hospital, Iowa City
Kansas City Veterans Affairs Medical Center, Kansas City
Clinical Research Institute, Wichita
Creighton University Dept. of Psychiatry, Omaha
University of Texas Southwestern Medical Center, Dallas
Central Texas Veterans Health Care System, Waco
VA Palo Alto Heathcare Systems, Palo Alto
VA Puget Sound Health Care System, Tacoma
Frontier Institute, Spokane
Yale University/Connecticut Mental Health Center, New Haven
University of North Carolina, Chapel Hill
Collaborators (1)
National Institute of Mental Health (NIMH)
NIH
Duke University
OTHER
University of North Carolina, Chapel Hill
OTHER
New York State Psychiatric Institute
OTHER